{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T02:54:38Z","timestamp":1721357678132},"reference-count":34,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2018.4350","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T06:48:26Z","timestamp":1522651706000},"source":"Crossref","is-referenced-by-count":1,"title":["Cotylenin A and tyrosine kinase inhibitors synergistically inhibit the growth of chronic myeloid leukemia cells"],"prefix":"10.3892","author":[{"given":"Fumiyoshi","family":"Ikejiri","sequence":"first","affiliation":[{"name":"Department of Oncology\/Hematology, Faculty of Medicine, Shimane University, Izumo, Shimane 6938501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Honma","sequence":"additional","affiliation":[{"name":"Department of Oncology\/Hematology, Faculty of Medicine, Shimane University, Izumo, Shimane 6938501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Oncology\/Hematology, Faculty of Medicine, Shimane University, Izumo, Shimane 6938501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Urano","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Shimane University, Izumo, Shimane 6938501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Suzumiya","sequence":"additional","affiliation":[{"name":"Department of Oncology\/Hematology, Faculty of Medicine, Shimane University, Izumo, Shimane 6938501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"key":"key20200713184804_b1-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"key20200713184804_b2-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: The prospective, multicentre Stop Imatinib (STIM) trial","volume":"11","author":"Mahon","year":"2010","journal-title":"Lancet Oncol"},{"key":"key20200713184804_b3-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J Clin Invest"},{"key":"key20200713184804_b4-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nature18288","article-title":"Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells","volume":"534","author":"Abraham","year":"2016","journal-title":"Nature"},{"key":"key20200713184804_b5-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/ijc.2910250208","article-title":"Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by componuds which induce differentiation of murine leukemia cells","volume":"25","author":"Collins","year":"1980","journal-title":"Int J Cancer"},{"key":"key20200713184804_b6-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1080\/10428190290026222","article-title":"Cotylenin A - a plant growth regulator as a differentiation-inducing agent against myeloid leukemia","volume":"43","author":"Honma","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"key20200713184804_b7-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bbamcr.2005.01.005","article-title":"Immediate up-regulation of the calcium-binding protein S100P and its involvement in the cytokinin-induced differentiation of human myeloid leukemia cells","volume":"1745","author":"Ishii","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"key20200713184804_b8-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-2141.2004.05326.x","article-title":"Induction of CCAAT\/enhancer binding protein-delta by cytokinins, but not by retinoic acid, during granulocytic differentiation of human myeloid leukaemia cells","volume":"128","author":"Ishii","year":"2005","journal-title":"Br J Haematol"},{"key":"key20200713184804_b9-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/leu.2008.347","article-title":"Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture","volume":"23","author":"Tsumura","year":"2009","journal-title":"Leukemia"},{"key":"key20200713184804_b10-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/stem.5530120402","article-title":"Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation","volume":"12","author":"Liebermann","year":"1994","journal-title":"Stem Cells"},{"key":"key20200713184804_b11-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1182\/blood.V99.6.2199","article-title":"Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and post-transcriptional up-regulation of p27(Kip1)","volume":"99","author":"Dimberg","year":"2002","journal-title":"Blood"},{"key":"key20200713184804_b12-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/cpr.12100","article-title":"Role of cell cycle regulatory molecules in retinoic acid- and vitamin D3-induced differentiation of acute myeloid leukaemia cells","volume":"47","author":"Hu","year":"2014","journal-title":"Cell Prolif"},{"key":"key20200713184804_b13-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1046\/j.1365-2141.2001.03029.x","article-title":"Differentiation of human acute myeloid leukaemia cells in primary culture in response to cotylenin A, a plant growth regulator","volume":"114","author":"Yamada","year":"2001","journal-title":"Br J Haematol"},{"key":"key20200713184804_b14-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0145-2126(03)00071-7","article-title":"Treatment of human promyelocytic leukemia in the SCID mouse model with cotylenin A, an inducer of myelomonocytic differentiation of leukemia cells","volume":"27","author":"Honma","year":"2003","journal-title":"Leuk Res"},{"key":"key20200713184804_b15-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/ijc.2910190119","article-title":"Properties of the K562 cell line derived from a patient with chronic myeloid leukemia","volume":"19","author":"Lozzio","year":"1977","journal-title":"Int J Cancer"},{"key":"key20200713184804_b16-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0145-2126(85)90060-8","article-title":"A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors","volume":"9","author":"Kishi","year":"1985","journal-title":"Leuk Res"},{"key":"key20200713184804_b17-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3892\/ijo.2015.3028","article-title":"Vitamin K2 and cotylenin A synergistically induce monocytic differentiation and growth arrest along with the suppression of c-MYC expression and induction of cyclin G2 expression in human leukemia HL-60 cells","volume":"47","author":"Maniwa","year":"2015","journal-title":"Int J Oncol"},{"key":"key20200713184804_b18-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212\u0394\u0394C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713184804_b19-ijo-52-06-2061","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1182\/blood.V77.6.1218.1218","article-title":"Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38\u2212 progenitor cells","volume":"77","author":"Terstappen","year":"1991","journal-title":"Blood"},{"key":"key20200713184804_b20-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"e1004414","DOI":"10.1371\/journal.pgen.1004414","article-title":"ATRA-induced cellular differentiation and CD38 expression inhibits acquisition of BCR-ABL mutations for CML acquired resistance","volume":"10","author":"Wang","year":"2014","journal-title":"PLoS Genet"},{"key":"key20200713184804_b21-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3892\/ijo.2015.2882","article-title":"Synergistic combination therapy with cotylenin A and vincristine in multiple myeloma models","volume":"46","author":"Takahashi","year":"2015","journal-title":"Int J Oncol"},{"key":"key20200713184804_b22-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2174\/187152012802650264","article-title":"A novel fusicoccin derivative preferentially targets hypoxic tumor cells and inhibits tumor growth in xenografts","volume":"12","author":"Kawakami","year":"2012","journal-title":"Anticancer Agents Med Chem"},{"key":"key20200713184804_b23-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3892\/ijo.2015.2979","article-title":"Combined treatment with tamoxifen and a fusicoccin derivative (ISIR-042) to overcome resistance to therapy and to enhance the antitumor activity of 5-fluorouracil and gemcitabine in pancreatic cancer cells","volume":"47","author":"Miyake","year":"2015","journal-title":"Int J Oncol"},{"key":"key20200713184804_b24-ijo-52-06-2061","first-page":"3659","article-title":"Cotylenin A, a differentiation-inducing agent, and IFN-alpha cooperatively induce apoptosis and have an antitumor effect on human non-small cell lung carcinoma cells in nude mice","volume":"63","author":"Honma","year":"2003","journal-title":"Cancer Res"},{"key":"key20200713184804_b25-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0014-5793(94)00949-X","article-title":"The fusicoccin receptor of plants is a member of the 14-3-3 superfamily of eukaryotic regulatory proteins","volume":"352","author":"Oecking","year":"1994","journal-title":"FEBS Lett"},{"key":"key20200713184804_b26-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1097-2765(00)80363-9","article-title":"Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding","volume":"4","author":"Rittinger","year":"1999","journal-title":"Mol Cell"},{"key":"key20200713184804_b27-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"49254","DOI":"10.1074\/jbc.M306614200","article-title":"Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic localization","volume":"278","author":"Fujita","year":"2003","journal-title":"J Biol Chem"},{"key":"key20200713184804_b28-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"el-Deiry","year":"1993","journal-title":"Cell"},{"key":"key20200713184804_b29-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1200\/JCO.2015.62.4718","article-title":"Tyrosine kinase inhibitor-associated cardiovascular toxicity in chronic myeloid leukemia","volume":"33","author":"Moslehi","year":"2015","journal-title":"J Clin Oncol"},{"key":"key20200713184804_b30-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11899-016-0309-2","article-title":"Long-term side effects of tyrosine kinase inhibitors in chronic myeloid leukemia","volume":"11","author":"Caldemeyer","year":"2016","journal-title":"Curr Hematol Malig Rep"},{"key":"key20200713184804_b31-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1182\/blood-2015-11-679985","article-title":"IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models","volume":"128","author":"\u00c5gerstam","year":"2016","journal-title":"Blood"},{"key":"key20200713184804_b32-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1182\/blood-2015-11-679928","article-title":"Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor-treated CML stem cells","volume":"128","author":"Zhang","year":"2016","journal-title":"Blood"},{"key":"key20200713184804_b33-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1182\/blood-2016-10-745588","article-title":"Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine","volume":"130","author":"Cheloni","year":"2017","journal-title":"Blood"},{"key":"key20200713184804_b34-ijo-52-06-2061","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/nm.4399","article-title":"Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells","volume":"23","author":"Kuntz","year":"2017","journal-title":"Nat Med"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T18:57:50Z","timestamp":1594666670000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2018.4350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,2]]},"references-count":34,"URL":"https:\/\/doi.org\/10.3892\/ijo.2018.4350","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,2]]}}}